Paraneoplastic Opsoclonus-myoclonus Syndrome with Anti-Hu and Anti-SOX-1 Antibodies after Immune-checkpoint Inhibitor Treatment Combined with Chemotherapy in a Patient with Small-cell Lung Cancer

A 69-year-old man with advanced small-cell lung cancer achieved partial remission after 3 courses of immunochemotherapy that included atezolizumab. Ten days after the last treatment, he developed paraneoplastic opsoclonus-myoclonus syndrome and required mechanical ventilation. Serology testing detec...

Descripción completa

Detalles Bibliográficos
Autores principales: Arai, Hironori, Utsu, Yoshikazu, Horio, Joji, Furukawa, Shogo, Kikkawa, Yuriko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8810250/
https://www.ncbi.nlm.nih.gov/pubmed/34980760
http://dx.doi.org/10.2169/internalmedicine.7167-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8810250/
https://www.ncbi.nlm.nih.gov/pubmed/34980760
http://dx.doi.org/10.2169/internalmedicine.7167-21

Ejemplares similares